Abstract
Contact investigation is an evidence-based intervention of multidrug-resistant tuberculosis (MDR-TB) to protect public health by interrupting the chain of transmission. In pursuit of contact investigation, patients’ MDR-TB status has to be disclosed to third parties (to the minimum necessary) for tracing the contacts. Nevertheless, disclosure to third parties often unintentionally leads the MDR-TB patients suffered from social discrimination and stigma. For this reason, patients are less inclined to reveal their MDR-TB status and becomes a significant issue in contact investigation. This issue certainly turns into a negative impact on the public interest. Tension between keeping MDR-TB status confidential and safeguarding public health arises in relation to this issue. Regarding MDR-TB management, patient compliance with treatment and contact investigation are equally important. Patients might fail to comply with anti-TB therapy and be reluctant to seek healthcare due to disclosure concerns. In order to have treatment adherence, MDRTB patients should not live through social discrimination and stigma arising from disclosure and TB team has a duty to support them as a mean of reciprocity. However, implementation of contact investigation as a public health policy can still be challenging even with promising reciprocal support to the patients because MDR-TB patients are living in different contexts and situations. There can be no straight forward settlement but an appropriate justification for each distinct context is needed to strike a balance between individual confidentiality and public interest.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abrham, A., R. Id, T.T. Dasa, F.W. Id, A. Asfaw, H. Mitiku, and E. Tesfaye. 2018. Tuberculosis patients are physically challenged and socially isolated: A mixed methods case-control study of health related quality of life in eastern Ethiopia. PLoS ONE 10 (1371): 1–14. https://doi.org/10.1371/journal.pone.0204697.
Ali, M. 2014. Treating tuberculosis as a social disease. The Lancet 383 (9936): 2195. https://doi.org/10.1016/S0140-6736(14)61063-1.
Almeida, D., C. Rodrigues, Z.F. Udwadia, A. Lalvani, G.D. Gothi, P. Mehta, and A. Mehta. 2003. Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention. Clinical Infectious Diseases 36 (12): e152–e154. https://doi.org/10.1086/374931.
Annas, G.J. 1976. Legal aspect of medical confidentialityin the occupational setting. Journal of Occupational Medicine 18 (8): 537–540.
Baluku, J.B., R.A. Kabamooli, N. Kajumba, M. Nabwana, D. Kateete, S. Kiguli, and I. Andia-Biraro. 2021. Contact tracing is associated with treatment success of index tuberculosis cases in Uganda. International Journal of Infectious Diseases 109: 129–136. https://doi.org/10.1016/j.ijid.2021.06.049.
Baral, S.C., Y. Aryal, R. Bhattrai, R. King, and J.N. Newell. 2014. The importance of providing counselling and financial support to patients receiving treatment for multi-drug resistant TB: Mixed method qualitative and pilot intervention studies. BMC Public Health 14: 46. https://doi.org/10.1186/1471-2458-14-46.
Bayona, J., A.M. Chavez-Pachas, E. Palacios, K. Llaro, R. Sapag, and M.C. Becerra. 2003. Contact investigations as a means of detection and timely treatment of persons with infectious multidrug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease 7 (12 Suppl 3): S501-509.
Centers for disease control and prevention. (2005). Guidelines for the investigation of contacts of persons with infectious tuberculosis. In MMWR (Vol. 54). Retrieved from https://www.cdc.gov/mmwr/pdf/rr/rr5415.pdf.
Centers for disease control and prevention. (2014b). Questions and answers about TB. Retrieved Mar 29, 2020, from CDC website: https://www.cdc.gov/tb/publications/faqs/qa_tbdisease.htm.
Council of Europe. Article 8. Right to respect for private and family life. European convention on human rights as amended by the provisions of protocol No. 14 (CETS no. 194) § (1998).
Cremers, A.L., M.M. De Laat, N. Kapata, R. Gerrets, K. Klipstein-Grobusch, and M.P. Grobusch. 2015. Assessing the consequences of stigma for tuberculosis patients in urban Zambia. PLoS ONE 10 (3): e0119861. https://doi.org/10.1371/journal.pone.0119861.
Dean, A.S., M. Zignol, D. Falzon, H. Getahun, and K. Floyd. 2014. HIV and multidrug-resistant tuberculosis: Overlapping epidemics. European Respiratory Journal 44: 251–254. https://doi.org/10.1183/09031936.
Deribew, A., Y. HaileMichael, M. Tesfaye, D. Desalegn, A. Wogi, and S. Daba. 2010. The synergy between TB and HIV co-infection on perceived stigma in Ethiopia. BMC ResearchNotes 3: 249. https://doi.org/10.1186/1756-0500-3-249.
de Vries, G., R. W. Aldridge, J. A. Caylà, W. H. Haas, A. Sandgren, N. A. van Hest, and I. Abubakar. "Tuberculosis in European union big cities working group: Epidemiology of tuberculosis in big cities of the European union and European economic area countries." Euro Surveill 19(9) (2014).
Faden, R. R., Shebaya, S., Faden, R. R., & Shebaya, S. (2019). Public Health Programs and Policies: Ethical Justifications. In A. C. Mastroianni, J. P. Kahn, & N. E. Kass (Eds.), The Oxford Handbook of Public Health Ethics (pp. 20–32). https://doi.org/10.1093/oxfordhb/9780190245191.013.3
Fana, T.E., E. Ijeoma, and L. Sotana. 2019. Knowledge, attitudes, and prevention practices of drug resistant tuberculosis in the eastern Cape province South Africa. Tuberculosis Research and Treatment 2019: 8978021. https://doi.org/10.1155/2019/8978021.
Fox, Gregory J., S.E. Barry, W.J. Britton, and G.B. Marks. 2013. Contact investigation for tuberculosis: A systematic review and meta-analysis. European Respiratory Journal 41 (1): 140–156. https://doi.org/10.1183/09031936.00070812.
Fox, Greg J., D.N. Sy, N.L.P. Hoa, L.T.N. Anh, N.T. Anh, N.B. Hoa, and N.V. Nhung. 2018. Household contact investigation for detection of tuberculosis in Vietnam. New England Journal of Medicine 378 (3): 221–229. https://doi.org/10.1056/NEJMoa1700209.
Franck, C., J.A. Seddon, A.C. Hesseling, H.S. Schaaf, D. Skinner, and L. Reynolds. 2014. Assessing the impact of multidrug-resistant tuberculosis in children: An exploratory qualitative study. BMC Infectious Diseases 14: 426. https://doi.org/10.1186/1471-2334-14-426.
General medical council. (2017). Confidentiality: good practice in handling patient information. In General Medical Council. Retrieved from https://www.gmc-uk.org/-/media/documents/gmc-guidance-fordoctors---confidentiality-good-practice-in-handlingpatient-information----70080105.pdf?.
Grut, L., L. Sanudi, S.H. Braathen, T. Jürgens, and A.H. Eide. 2015. Access to tuberculosis services for individuals with disability in rural Malawi, a qualitative study. PLoS ONE 10 (4): 1–9. https://doi.org/10.1371/journal.pone.0122748.
Hargreaves, S., K. Lönnroth, L.B. Nellums, I.D. Olaru, R.R. Nathavitharana, M. Norredam, and J.S. Friedland. 2017. Multidrug-resistant tuberculosis and migration to Europe. Clinical Microbiology and Infection 23 (3): 141–146. https://doi.org/10.1016/j.cmi.2016.09.009.
Heldal, E., J.V. Kuyvenhoven, F. Wares, G.B. Migliori, L. Ditiu, K. Fernandez De La Hoz, and D. Garcia. 2008. Diagnosis and treatment of tuberculosis in undocumented migrants in low- or intermediateincidence countries. International Journal of Tuberculosis and Lung Disease 12 (8): 878–888.
Heymann, D. L., Shindo, N., & WHO Scientific and Technical Advisory Group for Infectious Hazards. 2020. COVID-19: What is next for public health? Lancet 395 (10224): 542–545. https://doi.org/10.1016/S0140-6736(20)30374-3.
Huang, C.C., M.C. Becerra, R. Calderon, C. Contreras, J. Galea, L. Grandjean, and M. Murray. 2020. Isoniazid preventive therapy in contacts of multidrug-resistant tuberculosis. American Journal of Respiratory and Critical Care Medicine 202 (8): 1159–1168. https://doi.org/10.1164/rccm.201908-1576OC.
Jenkins, H.E., M. Gegia, J. Furin, I. Kalandadze, U. Nanava, T. Chakhaia, and T. Cohen. 2014. Geographical heterogeneity of multidrug-resistant tuberculosis in Georgia, January 2009 to June 2011. Eurosurveillance 19 (11): 20743. https://doi.org/10.2807/1560-7917.es2014.19.11.20743.
Jenkins, Helen E, & Yuen, C. M. (2018). The burden of multidrug-resistant tuberculosis in children. Int J Tuberc Lung Dis, 22(5), 3–6. https://doi.org/10.5588/ijtld.17.0357Kottow
Kottow, M.H. 1986. Medical confidentiality: an intransigent and absolute obligation. Journal of Medical Ethics 12 (3): 117–122. https://doi.org/10.1136/jme.12.3.117.
Krishnan, L., T. Akande, A.V. Shankar, K.N. McIntire, C.R. Gounder, A. Gupta, and W.T. Yang. 2014. Gender-related barriers and delays in accessing tuberculosis diagnostic and treatment services: A systematic review of qualitative studies. Tuberculosis Research and Treatment 11: 2014. https://doi.org/10.1155/2014/215059.
Lange, C., Abubakar, I., Alffenaar, J. W. C., Bothamley, G., Caminero, J. A., Carvalho, A. C. C., Cirillo, D. M. (2014). Management of patients with multidrug-resistant/ extensively drugresistant tuberculosis in Europe: A TBNET consensus statement. European Respiratory Journal, 44(1), 23–63. https://doi.org/10.1183/09031936.00188313
Lee, J.H., and J.H. Chang. 2001. Drug-resistant tuberculosis in a tertiary referral teaching hospital of Korea. The Korean Journal of Internal Medicine 16 (3): 173–179. https://doi.org/10.3904/kjim.2001.16.3.173.
Li, S.P., Z.Y. Zheng, Q.Y. Meng, and C.H. Yuan. 2013. Barriers to tuberculosis care for drug users in two provinces of China: A qualitative study. International Journal of Tuberculosis and Lung Disease 17 (10): 1358–1363. https://doi.org/10.5588/ijtld.12.0784.
Li, W. Bin., Y.Q. Zhang, J. Xing, Z.Y. Ma, Y.H. Qu, and X.X. Li. 2015. Factors associated with primary transmission of multidrug-resistant tuberculosis compared with healthy controls in Henan Province China. Infectious Diseases of Poverty 4 (1): 1–7. https://doi.org/10.1186/s40249-015-0045-1.
McNally, T.W., G. De Wildt, G. Meza, and C.M.D. Wiskin. 2019. Improving outcomes for multi-drug-resistant tuberculosis in the Peruvian Amazon—a qualitative study exploring the experiences and perceptions of patients and healthcare professionals. BMC Health Services Research 19 (1): 594. https://doi.org/10.1186/s12913-019-4429-y.
Moore, D.A.J. 2016. What can we offer to 3 million MDRTB household contacts in 2016? BMC Medicine 14: 64. https://doi.org/10.1186/s12916-016-0610-x.
Morens, D.M., and A.S. Fauci. 2013. Emerging infectious diseases: Threats to human health and global stability. PLoS Pathogens 9 (7): 7–9. https://doi.org/10.1371/journal.ppat.1003467.
O’Connor, J., and G. Matthews. 2011. Informational privacy, public health, and state laws. American Journal of Public Health 101 (10): 1845–1850. https://doi.org/10.2105/AJPH.2011.300206.
Reichler, M.R., A. Khan, T.R. Sterling, H. Zhao, J. Moran, J. McAuley, P. Bessler, and B. Mangura. 2018. Risk and timing of tuberculosis among close contacts of persons with infectious tuberculosis. The Journal of Infectious Diseases 218 (6): 1000–1008.
Selgelid, M.J. 2008. Ethics, tuberculosis and globalization. Public Health Ethics 1: 10–20.
Shah, N.S., C.M. Yuen, M. Heo, A.W. Tolman, and M.C. Becerra. 2014. Yield of contact investigations in households of patients with drug-resistant tuberculosis: Systematic review and meta-analysis. Clinical Infectious Diseases 58 (3): 381–391. https://doi.org/10.1093/cid/cit643.
Skinner, D., and M. Claassens. 2016. It’s complicated: Why do tuberculosis patients not initiate or stay adherent to treatment? A qualitative study from South Africa. BMC Infectious Diseases 16: 712. https://doi.org/10.1186/s12879-016-2054-5.
Smelyanskaya, M., & John, D. (2016). Stop TB Partership Key population breif: Rural population. Retrieved from http://www.stoptb.org/assets/documents/resources/publications/acsm/kp_rural_spreads.pdf.
Sterling, T.R., D. Thompson, R.L. Stanley, P.D. McElroy, A. Madison, K. Moore, and S. Bur. 2000. A multistate outbreak of tuberculosis among members of a highly mobile social network: Implications for tuberculosis elimination. International Journal of Tuberculosis and Lung Disease 4 (11): 1066–1073.
Taylor, M.J. 2015. Legal bases for disclosing confidential patient information for public health: Distinguishing between health protection and health improvement. Medical Law Review 23 (3): 348–374. https://doi.org/10.1093/medlaw/fwv018.
World Health Organization. 2019. Global tuberculosis report 2019. Geneva, Switzerland: WHO.
World Health Organization. (2012). Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries. In World Health Organization. Retrieved from https://apps.who.int/iris/bitstream/handle/10665/77741/9789241504492_eng.pdf.
World Health Organization. (2014). Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. In World Health Organization. Retrieved from World Health Organization website: https://apps.who.int/iris/bitstream/handle/10665/130918/ 9789241548809_eng.pdf.
World Health Organization. (2015a). The end TB strategy. Retrieved from https://www.who.int/tb/ End_TB_ brochure.pdf.
World Health Organization. (2015b). WHO global disability action plan 2014–2021: Better health for all people with disability. Retrieved from https://apps.who.int/iris/bitstream/handle/10665/199544/ 978924150961 _eng.pdf.
World Health Organization. (2017). Ethics guidance for the implementation of the end TB strategy. Retrieved from World Health Organization website: https://apps.who.int/iris/bitstream/handle/10665/254820/ 9789241512114-eng.pdf.
Wouters, E., N. Sommerland, C. Masquillier, A. Rau, M. Engelbrecht, A.J. Van Rensburg, and Van Damme, W. 2020. Unpacking the dynamics of double stigma: How the HIV-TB coepidemic alters TB stigma and its management among healthcare workers. BMC Infectious Diseases 20 (1): 106. https://doi.org/10.1186/s12879-020-4816-3.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, I declare that there is no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Oo, H.S., Borry, P. Contact investigation in multidrug-resistant tuberculosis: ethical challenges. Monash Bioeth. Rev. (2024). https://doi.org/10.1007/s40592-024-00188-0
Accepted:
Published:
DOI: https://doi.org/10.1007/s40592-024-00188-0